The PURE Report: Oncology 2022
The PURE Report: Neurology 2022
The PURE Report: Immunology 2022
The PURE Report: Patient 2022
The PURE Report consists of two separate reports: a syndicated research plus a separate report with company specific insights
PART I: Customer Perception
Key insights into customer needs, expectations, perceptions, and best-in-class manufacturer mentions
PART II: Industry Benchmarking
Manufacturer scores and rankings across 7 key indices with a spotlight on individual manufacturer
Part I: View into Syndicated Report
Sample Finding #1 HCP Go-To Partner for Reimbursement Support
Pharmacy Benefits
(oral/self-injectable)
Medical Benefits
(buy & bill)
Hospital Centers are 20% more likely to partner with in-house pharmacies on pharmacy benefits
Sample Finding #2 HCP Communication Preferences on Patient Updates
Sample Finding #3 HCP Program Awareness
How HCPs Learn About Patient Support Programs
Part II: View Into Company-Specific Insights
The company-dedicated section of the PURE Report addresses company-specific feedback from respondents in the form of unaided free-text feedback as well as numeric rankings in relation to other top-performing programs within the therapeutic area.
01.
Industry Dashboard
Individual company scoring across the 7 PURE Report indices highlighting best/worst performers
02.
Company Analysis
Company rating along the 7 PURE indices and ranking compared to competitors
03.
Unaided Feedback
Unaided open-text feedback about company’s support program
04.
Considerations
Who We Spoke With
The screener and background participant information was carefully crafted to ensure participant familiarity with the space, sample representation of industry population, and segmentation and detection of trends that support programs can act on. For example, research participants are:
- Based on role, not title: Participants selected based on their day-to-day activities
- 150 MDs and 350 support staff: Total sample size per therapeutic area reaches 500 participants to ensure statistically significant insights (total sample size exceed 1,400 HCPs to date)
- Geographically diverse: Participants proportionally represented based on geographic location
- Split between hospital systems and community practice: Proportional mix of stakeholders from various provider channels based on therapeutic area
- Representative of various practice sizes and dispense capabilities: Appropriate mix of large, medium, and smaller providers with differing outpatient pharmacy capabilities